Evidence map›Paper›PMID 42205957›Full record

ArticleFrontiers in psychology2026

Visual attention predicts risky supplement decisions in recreational fitness: evidence from a quiet eye experiment.

René Paasch, Gunnar Mau

Abstract read
In one paragraph

Article in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

René PaaschDepartment of Health and Sport Sciences, DHGS Deutsche Hochschule für Gesundheit und Sport GmbH, Berlin, Germany.
Gunnar MauDepartment of Health Sciences, Hochschule Magdeburg-Stendal, Magdeburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Risky, high-stimulant supplement use and IPED-like products are increasingly common in recreational fitness environments and represent a relevant public health and harm-reduction concern. While psychosocial correlates of such decisions have been widely examined, less is known about visuocognitive processes involved in the real-time evaluation of supplement-related information at the point of choice. Quiet Eye (QE), defined as the final fixation before an action, has been described as a marker of attentional stability but has not yet been examined in the context of supplement-related risk decision-making. Methods: A laboratory eye-tracking study was conducted with 166 recreational fitness athletes. Participants viewed a standardized supplement stimulus containing reward-related and warning-related cues, completed a binary task-based risky-choice task, and reported their intention to use the risky product. Measures of QE fixation duration, psychosocial risk constructs, and experimentally induced cognitive load were obtained. Logistic and linear regression models were estimated using standardized predictors. Results: Longer QE fixation on warning cues was associated with a lower likelihood of selecting the risky supplement (OR = 0.50, Conclusion: The findings indicate that warning-related QE fixation is associated with lower intention and a reduced likelihood of risky choice in supplement-related decisions. QE metrics are interpreted as visuocognitive markers of attentional allocation during the final phase of decision-making rather than as causal determinants. Together with established psychosocial correlates, visuocognitive attention may constitute an additional descriptive component in understanding supplement-related risk decision processes, with potential relevance for harm-reduction approaches in visually dense fitness environments.

Indexed as

decision-makingeye-trackingquiet eyerisk acceptancerisk perceptionsupplement usevisual attention

Identifiers

PMID42205957
PMCPMC13201248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.